ARTICLE | Distillery Therapeutics
Gastrointestinal; autoimmune disease
July 25, 2018 3:30 PM UTC
Mouse studies suggest inhibiting LRRK2 could help treat colitis and Crohn disease. In dendritic cells from eight Crohn patients, four LRRK2 inhibitor tool compounds decreased levels of inflammatory cy...
BCIQ Company Profiles
BCIQ Target Profiles